A proteomic analysis of excreted and circulating proteins from obese patients following two different weight-loss strategies

AA Alfadda, AA Turjoman, AS Moustafa, MY Al-Naami, MA Chishti, RM Sallam, David Gibson, MW Duncan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Bariatric surgery is the most successful therapeutic approach to weight loss, but how it leads to weight loss, and how it resolves obesity-related complications, including type-2 diabetes, are poorly understood. This study, comprising two groups of individuals, one on a low-calorie diet (n = 5) and one undergoing bariatric surgery (n = 7), used both targeted and untargeted proteomic approaches to determine changes in protein levels pre- and post-intervention (i.e. 3-6 months later). Changes were observed in both circulating and excreted proteins following weight loss. Targeted multiplexed biochip arrays measured 12 plasma peptides/proteins involved in metabolism and inflammation: C-peptide, ferritin, interleukin-6, interleukin-1 alpha, resistin, insulin, tumor necrosis factor alpha, leptin, plasminogen-activator inhibitor-1, adiponectin, cystatin C, and C-reactive protein. Following a low-calorie diet, plasma insulin and C-reactive protein levels were significantly reduced (P = 0.045 and P = 0.030, respectively); adiponectin increased and leptin decreased following surgery (P = 0.014 and P = 0.005, respectively). Untargeted proteomic analysis employing 2D difference in-gel electrophoresis (DIGE) showed 28 protein spots with ≥1.5-fold changes in expression following weight loss by a low-calorie diet; comparison of pre- and post-intervention urine samples from the bariatric surgery group showed changes in excretion of 110 protein spots. The combination of targeted protein analysis by multiplexed arrays and an exploratory (i.e. an unbiased or discovery) proteomic assessment of hundreds of proteins offers valuable insights into the mechanistic differences between alternative weight-loss strategies. This is a powerful hypothesis-generating approach to study complex, multifactorial syndromes such as obesity. The findings that arise from these studies can then be validated in targeted, hypothesis-directed investigations.
LanguageEnglish
Pages568-580
Number of pages12
JournalExperimental Biology and Medicine
Volume239
Issue number5
Early online date25 Mar 2014
DOIs
Publication statusPublished - 1 May 2014

Fingerprint

Leptin
Proteomics
Weight Loss
Caloric Restriction
Bariatric Surgery
Adiponectin
Proteins
C-Reactive Protein
Obesity
Insulin
Resistin
Cystatin C
Protein Array Analysis
Interleukin-1alpha
C-Peptide
Plasminogen Activator Inhibitor 1
Ferritins
Type 2 Diabetes Mellitus
Electrophoresis
Blood Proteins

Cite this

Alfadda, AA ; Turjoman, AA ; Moustafa, AS ; Al-Naami, MY ; Chishti, MA ; Sallam, RM ; Gibson, David ; Duncan, MW. / A proteomic analysis of excreted and circulating proteins from obese patients following two different weight-loss strategies. In: Experimental Biology and Medicine. 2014 ; Vol. 239, No. 5. pp. 568-580.
@article{70509a9d572a4ca4a5ca6866a5f1550c,
title = "A proteomic analysis of excreted and circulating proteins from obese patients following two different weight-loss strategies",
abstract = "Bariatric surgery is the most successful therapeutic approach to weight loss, but how it leads to weight loss, and how it resolves obesity-related complications, including type-2 diabetes, are poorly understood. This study, comprising two groups of individuals, one on a low-calorie diet (n = 5) and one undergoing bariatric surgery (n = 7), used both targeted and untargeted proteomic approaches to determine changes in protein levels pre- and post-intervention (i.e. 3-6 months later). Changes were observed in both circulating and excreted proteins following weight loss. Targeted multiplexed biochip arrays measured 12 plasma peptides/proteins involved in metabolism and inflammation: C-peptide, ferritin, interleukin-6, interleukin-1 alpha, resistin, insulin, tumor necrosis factor alpha, leptin, plasminogen-activator inhibitor-1, adiponectin, cystatin C, and C-reactive protein. Following a low-calorie diet, plasma insulin and C-reactive protein levels were significantly reduced (P = 0.045 and P = 0.030, respectively); adiponectin increased and leptin decreased following surgery (P = 0.014 and P = 0.005, respectively). Untargeted proteomic analysis employing 2D difference in-gel electrophoresis (DIGE) showed 28 protein spots with ≥1.5-fold changes in expression following weight loss by a low-calorie diet; comparison of pre- and post-intervention urine samples from the bariatric surgery group showed changes in excretion of 110 protein spots. The combination of targeted protein analysis by multiplexed arrays and an exploratory (i.e. an unbiased or discovery) proteomic assessment of hundreds of proteins offers valuable insights into the mechanistic differences between alternative weight-loss strategies. This is a powerful hypothesis-generating approach to study complex, multifactorial syndromes such as obesity. The findings that arise from these studies can then be validated in targeted, hypothesis-directed investigations.",
author = "AA Alfadda and AA Turjoman and AS Moustafa and MY Al-Naami and MA Chishti and RM Sallam and David Gibson and MW Duncan",
year = "2014",
month = "5",
day = "1",
doi = "10.1177/1535370214523894",
language = "English",
volume = "239",
pages = "568--580",
journal = "Experimental Biology and Medicine",
issn = "1535-3702",
number = "5",

}

A proteomic analysis of excreted and circulating proteins from obese patients following two different weight-loss strategies. / Alfadda, AA; Turjoman, AA; Moustafa, AS; Al-Naami, MY; Chishti, MA; Sallam, RM; Gibson, David; Duncan, MW.

In: Experimental Biology and Medicine, Vol. 239, No. 5, 01.05.2014, p. 568-580.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A proteomic analysis of excreted and circulating proteins from obese patients following two different weight-loss strategies

AU - Alfadda, AA

AU - Turjoman, AA

AU - Moustafa, AS

AU - Al-Naami, MY

AU - Chishti, MA

AU - Sallam, RM

AU - Gibson, David

AU - Duncan, MW

PY - 2014/5/1

Y1 - 2014/5/1

N2 - Bariatric surgery is the most successful therapeutic approach to weight loss, but how it leads to weight loss, and how it resolves obesity-related complications, including type-2 diabetes, are poorly understood. This study, comprising two groups of individuals, one on a low-calorie diet (n = 5) and one undergoing bariatric surgery (n = 7), used both targeted and untargeted proteomic approaches to determine changes in protein levels pre- and post-intervention (i.e. 3-6 months later). Changes were observed in both circulating and excreted proteins following weight loss. Targeted multiplexed biochip arrays measured 12 plasma peptides/proteins involved in metabolism and inflammation: C-peptide, ferritin, interleukin-6, interleukin-1 alpha, resistin, insulin, tumor necrosis factor alpha, leptin, plasminogen-activator inhibitor-1, adiponectin, cystatin C, and C-reactive protein. Following a low-calorie diet, plasma insulin and C-reactive protein levels were significantly reduced (P = 0.045 and P = 0.030, respectively); adiponectin increased and leptin decreased following surgery (P = 0.014 and P = 0.005, respectively). Untargeted proteomic analysis employing 2D difference in-gel electrophoresis (DIGE) showed 28 protein spots with ≥1.5-fold changes in expression following weight loss by a low-calorie diet; comparison of pre- and post-intervention urine samples from the bariatric surgery group showed changes in excretion of 110 protein spots. The combination of targeted protein analysis by multiplexed arrays and an exploratory (i.e. an unbiased or discovery) proteomic assessment of hundreds of proteins offers valuable insights into the mechanistic differences between alternative weight-loss strategies. This is a powerful hypothesis-generating approach to study complex, multifactorial syndromes such as obesity. The findings that arise from these studies can then be validated in targeted, hypothesis-directed investigations.

AB - Bariatric surgery is the most successful therapeutic approach to weight loss, but how it leads to weight loss, and how it resolves obesity-related complications, including type-2 diabetes, are poorly understood. This study, comprising two groups of individuals, one on a low-calorie diet (n = 5) and one undergoing bariatric surgery (n = 7), used both targeted and untargeted proteomic approaches to determine changes in protein levels pre- and post-intervention (i.e. 3-6 months later). Changes were observed in both circulating and excreted proteins following weight loss. Targeted multiplexed biochip arrays measured 12 plasma peptides/proteins involved in metabolism and inflammation: C-peptide, ferritin, interleukin-6, interleukin-1 alpha, resistin, insulin, tumor necrosis factor alpha, leptin, plasminogen-activator inhibitor-1, adiponectin, cystatin C, and C-reactive protein. Following a low-calorie diet, plasma insulin and C-reactive protein levels were significantly reduced (P = 0.045 and P = 0.030, respectively); adiponectin increased and leptin decreased following surgery (P = 0.014 and P = 0.005, respectively). Untargeted proteomic analysis employing 2D difference in-gel electrophoresis (DIGE) showed 28 protein spots with ≥1.5-fold changes in expression following weight loss by a low-calorie diet; comparison of pre- and post-intervention urine samples from the bariatric surgery group showed changes in excretion of 110 protein spots. The combination of targeted protein analysis by multiplexed arrays and an exploratory (i.e. an unbiased or discovery) proteomic assessment of hundreds of proteins offers valuable insights into the mechanistic differences between alternative weight-loss strategies. This is a powerful hypothesis-generating approach to study complex, multifactorial syndromes such as obesity. The findings that arise from these studies can then be validated in targeted, hypothesis-directed investigations.

U2 - 10.1177/1535370214523894

DO - 10.1177/1535370214523894

M3 - Article

VL - 239

SP - 568

EP - 580

JO - Experimental Biology and Medicine

T2 - Experimental Biology and Medicine

JF - Experimental Biology and Medicine

SN - 1535-3702

IS - 5

ER -